News

Sorted by: Date | Title

Targeted therapy for children with leukemia can provide substantial benefit, study finds

February 09, 2021
Genomic testing of patient leukemia cells uncovers genetic alterations that can be targeted by drug therapies in many patients.

Stuart H. Orkin Receives the 2021 ISSCR Tobias Lecture Award

February 04, 2021
Established in 2015 and supported by the Tobias Foundation, the prize recognizes original and promising basic hematology research as well as direct translational or clinical research related to cell therapy in hematological disorders.

In landmark study, an arthritis drug appears to prevent deadly acute graft-versus-host disease after bone marrow transplant

January 15, 2021
Abatacept (Orencia) reduces rates of acute GVHD, boosts survival in Phase 2 multicenter trial.

Dana-Farber/Boston Children's Faculty Named 2021 Top Doctors

January 05, 2021
Boston magazine has named a number of Dana-Farber/Boston Children’s Cancer and Blood Disorders Center faculty members to its annual "Top Doctors" guide.
Showing 1-4 of 4 items